Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Inari Medical Stock Gets RS Rating Upgrade — Dec 11th, 2024

Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Inari Medical Stock Gets RS Rating Upgrade — Dec 11th, 2024

Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Insulet price target raised to $260 from $250 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/insulet-price-target-raised-to-260-from-250-at-btig BTIG raised the firm’s price target on Insulet to $260 from $250 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in MedTech. The sector had “solid re...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Inari Medical Stock Gets RS Rating Upgrade — Dec 11th, 2024

Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High — Nov 8th, 2024

Costco stock hit a buy point as it continues its recent rally. An insulin pump maker soared to a yearlong high after the company's earnings report. Continue reading View comments...

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues — Nov 8th, 2024

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." Continue reading View comments...